Sibutramine
A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder
Abbott · Phase 3 · Completed · Enrollment 304
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Registry arm not named | n/r | n/r | n/r | n/r |
Not shown
- Registry arm not named: endpoint not reported